Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate Seroprevalence of Antibodies to AAV8 and Assessment of Biomarkers in Patients With Late-Onset Pompe Disease

NCT06150820 is registered in ClinicalTrials.gov with Astellas Gene Therapies as lead sponsor.

NCT NCT06150820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06150820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate Seroprevalence of Antibodies to AAV8 and Assessment of Biomarkers in Patients With Late-Onset Pompe Disease
Lead sponsor
Astellas Gene Therapies
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 1, 2024
Completion date
June 30, 2027
Enrollment
119 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

pompe disease (late-onset)